Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

IsraelRecruitingPHASE3

Conditions

Myasthenia Gravis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The Neurology Group, Pomona, California, United States

  • Advanced Neurology of Colorado, Fort Collins, Colorado, United States

  • University of Connecticut, Farmington, Connecticut, United States

  • SFM Clinical Research LLC, Boca Raton, Florida, United States

  • HSHS St. Elizabeth's Hospital, O'Fallon, Illinois, United States

  • Henry Ford Hospital, Detroit, Michigan, United States

  • Velocity Clinical Research, Inc., Raleigh, North Carolina, United States

  • Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States

  • Texas Neurology, Dallas, Texas, United States

  • Rambam Medical Center, Haifa, Israel

  • Sourasky Medical Center, Tel Aviv, Israel

  • HOCH Health Ostschweiz Kantonsspital St.Gallen, Sankt Gallen, Switzerland

Study leads
  • Janssen Research & Development, LLC Clinical Trial

    Study Director

    Janssen Research & Development, LLC